Citations

Showing 10 of 108104 citations.

Outcomes with chemotherapy for metastatic non-small cell lung cancer (mNSCLC) in patients previously treated with immune checkpoint inhibitors (CPI).
Elnair, Radowan , Chang, Guy vin, Powell, Steven , Sumey, Christopher , Bleeker, Jonathan

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e21119-e21119

10.1200/jco.2018.36.15_suppl.e21119 Get It

A randomized phase II study of anti-PD1 antibody [MK-3475 (Pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced merkel cell carcinoma (Alliance A091605).
Chmura, Steven J. , Allred, Jacob B., Salama, Joseph K. , Al‐Hallaq, Hania , Hsu, Charles C., Kozloff, M., Luke, Jason J. , Yom, Sue S. , Münster, Pamela N. , Schwartz, Gary K.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS9599-TPS9599

10.1200/jco.2018.36.15_suppl.tps9599 Get It

Real-world utilization and patient outcomes associated with pembrolizumab in advanced melanoma in US academic centers and affiliated satellite clinics.
Liu, Frank Xiaoqing, Macahilig, Cynthia, Harshaw, Qing, Shillington, Alicia C. , Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e21500-e21500

10.1200/jco.2018.36.15_suppl.e21500 Get It

Factors predicting the use of immunotherapy for patients with advanced melanoma.
Shillington, Alicia C. , Macahilig, Cynthia, Harshaw, Qing, Liu, Frank Xiaoqing, Joseph, Richard W. , Diede, Scott J. , Dave, Vaidehi

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9571-9571

10.1200/jco.2018.36.15_suppl.9571 Get It

Chemoimmunotherapy combination after PD-1 inhibitor failure to improve clinical outcomes in metastatic melanoma patients.
Aguilera, Jesus Vera, Bangalore, Anagha, Failing, Jarrett, Kottschade, Lisa A. , Block, Matthew S. , Dronca, Roxana , Yan, Yiyi , Paludo, Jonas , McWilliams, Robert R. , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9558-9558

10.1200/jco.2018.36.15_suppl.9558 Get It

Interim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients.
Myers, John W., Hale, Diane F. , Brown, Tommy A., Vreeland, Timothy J. , Andtbacka, Robert Hans Ingemar, Berger, Adam C. , Terando, Alicia M. , Faries, Mark B. , Peoples, George E. , Clifton, Guy T. , Jakub, James W. , Sussman, Jonathan

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9525-9525

10.1200/jco.2018.36.15_suppl.9525 Get It

5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001.
Hamid, Omid , Hodi, F. Stephen , Hwu, Wen‐Jen , Dronca, Roxana , Mitchell, Tara C. , Patnaik, Amita , Zarour, Hassane M. , Jensen, Erin , Ibrahim, Nageatte , Ahsan, Sama, Robert, Caroline , Daud, Adil , Kefford, Richard , Wolchok, Jedd D. , Hersey, Peter , Joseph, Richard W. , Weber, Jeffrey S. , Joshua, Anthony M. , Ribas, Antoni

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9516-9516

10.1200/jco.2018.36.15_suppl.9516 Get It

Phase 2 trial of the IDO pathway inhibitor indoximod plus checkpoint inhibition for the treatment of patients with advanced melanoma.
Rixe, Olivier , Ward, John Harris, Drabick, Joseph J. , Shaheen, Montaser , Vahanian, Nicholas N., Link, Charles J., Zakharia, Yousef , Milhem, Mohammed , Munn, David H. , Kennedy, Eugene Paul , McWilliams, Robert R.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9512-9512

10.1200/jco.2018.36.15_suppl.9512 Get It

Association of CDKN2A gene alteration with high expression of PD-L1.
Azzouqa, A.G., Lou, Yanyan , Zhang, Yan , Marin‐Acevedo, Julian A. , Manochakian, Rami

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9102-9102

10.1200/jco.2018.36.15_suppl.9102 Get It

Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC.
Ross, Helen J. , Kozono, David , Urbanic, James J., DuFrane, Carter, Bāra, Ilze, Gandhi, Mayank , Schulze, Katja , Brockman, Jane Michelle, Wang, Xiaofei F., Stinchcombe, Tom, Kozono, David E , Williams, Terence M. , Vokes, Everett E. , Stinchcombe, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS8585-TPS8585

10.1200/jco.2018.36.15_suppl.tps8585 Get It